Marigold

Marigold (Calendula officinalis L.): A Comprehensive Reference

1. Identity and Botanical Classification

Botanical Name and Taxonomy

Calendula officinalis, also known as Mary's gold, common marigold, the pot marigold, Scotch marigold, or ruddles, is a flowering plant in the daisy family, Asteraceae. The name Calendula comes from the Latin word "calendas," which means "first of the month." The genus name Calendula is a modern Latin diminutive of calendae, meaning "little calendar," "little clock," or possibly "little weather-glass." The common name "marigold," a contraction of "Mary's gold" used especially for Calendula officinalis, refers to the Virgin Mary.

Calendula officinalis belongs to the genus Calendula of the Asteraceae family, which contains 15 species, and it is considered to have originated in the southwest Mediterranean region. It is probably native to southern Europe, but its long history of cultivation makes its precise origin unknown, and it is widely naturalised.

A critical taxonomic distinction must be observed: Calendula officinalis must not be confused with Tagetes species, of which the French, African, and Mexican marigolds are common. These have different properties and must not be used for herbal teas; instead, those plants are used for warts and also as insecticides or weedkillers. C. officinalis is the most commonly cultivated and used species; popular herbal and cosmetic products named "Calendula" invariably derive from it.

Plant Description

C. officinalis is a sessile, hispid, acute, oblanceolate, annual, or biennial herbaceous plant that is between 30 and 60 centimetres in height. It is an annual herb with yellow to orange flowers, native to the Mediterranean region. The plant is a short-lived aromatic herbaceous perennial, growing to 80 cm tall, with sparsely branched lax or upright stems.

Geographic Distribution

Calendula is widely distributed in Europe, northern Africa, and southwestern Asia, although the genus probably originated in the southwestern Mediterranean region. C. officinalis is cultivated worldwide; in Europe it is occasionally encountered and sometimes naturalized.

Common Forms and Preparations

The medicinally used part is the flower. The HMPC conclusions cover calendula flower preparations that are obtained by drying and comminuting the flowers, or by putting the plant material in a solvent (such as ethanol or olive oil) to dissolve compounds and form a liquid extract. Herbal medicines containing calendula flower preparations are usually available as infusions to be applied to the lining of the mouth or the skin, and in liquid and semi-solid forms to be applied to the skin.

According to the European Scientific Cooperative on Phytotherapy (ESCOP) and EMA monographs, calendula's preferred mode of administration is the oral or cutaneous route. Applicable dosage forms include gels, creams, liquids, ointments, solutions, and sprays. Preparations currently in use include carophyllenic ointment, containing carotenoids extracted from the flowers, and pot marigold tincture. In addition, calendula is used in the food industry because its flowers are edible and can be used fresh in salads or dried as a dye.

2. Traditional and Historical Use

Antiquity: Greek, Roman, and Egyptian Traditions

C. officinalis ranks among the oldest cultivated flowers, first described in the third century B.C.; ancient Romans and Greeks used calendula flowers in many rituals and ceremonies, to make crowns or garlands. Flowers were used in ancient Greek, Roman, Middle Eastern, and Indian cultures as a medicinal herb, as well as a dye for fabrics, foods, and cosmetics. Ancient Egyptians valued it as a rejuvenating herb. Hindus used it to decorate temple altars. Persians and Greeks garnished and flavored food with the flower petals.

Medieval and Renaissance Europe

The plant has been in cultivation and used for medicinal purposes only since the 12th century and has a long history of use. In the Middle Ages, calendula was used for hepatic disorders, poisoning, and cardiac tonicity. Doctors realized that the plant could stop bleeding and promote wound healing around the 18th century. In medieval Europe, Hildegard von Bingen recommended it for liver and gallbladder ailments. By the Renaissance, Pot Marigold was fixed in herbals across Europe, often mixed into salves and plasters for battlefield injuries.

Calendula was used in historic times for headaches, red eye, fever, and toothaches. As late as the 17th century, Nicholas Culpeper claimed calendula benefited the heart, but it was not considered an especially efficacious medicine.

Culinary Use

The most common use in historic times was culinary, and the plant was used for both its colour and its flavour. The flowers were used in dumplings, wine, oatmeal, and puddings. In English cuisine, calendula were often cooked in the same pot with spinach, or used to flavor stewed birds. The flowers of marigold are edible and can be used fresh in salads or dried as a colouring agent for cheese or as a substitute for saffron.

Ayurvedic and Asian Traditions

Calendula officinalis is extensively used in Homoeopathic, Unani, and Ayurvedic systems of medication as diaphoretic, analgesic, antiseptic, and anti-inflammatory agents, and is used to treat gynaecological issues, gastro-intestinal disorders, inflammations of oral and pharyngeal mucosa, eye problems, skin injuries and certain burns, poor eyesight, and menstrual irregularities.

Traditional Indications Recognized by Regulatory Bodies

The German Commission E Monographs approve Calendula officinalis for inflammation of the mouth and pharynx (throat), wounds and burns; traditional medicine uses it as antiphlogistic, antiseptic, antispasmodic, aperient, astringent, cholagogue, diaphoretic, emmenagogue, stimulant, and vulnerary. It has a long history as a traditional remedy for inflammation, ulcers, skin and digestive problems, nervousness, insomnia, and many other ailments.

3. Key Constituents and Active Compounds

Overview of Phytochemical Classes

Notably, the bioactive compounds of C. officinalis include carotenoids, polyphenolic compounds, terpenoids, triterpeneol esters, triterpenoids, saponins, sterols, flavonoids, essential oils, amino acids, and tocopherols. Dried flower heads are characterized by the presence of steroids, terpenoids, free and esterified triterpenic alcohols (faradiol, arnidiol, and calenduladiol, mainly as myristate), phenolic acids, flavonoids (quercetin, rutin, narcissin, isorhamnetin, kaempferol), carotenoids, and other minor compounds.

Triterpenes and Triterpenic Alcohols

The main characteristic constituents include triterpene saponins (mainly oleanolic acid glycosides), free and esterified triterpene alcohols (especially faradiol mono- and diesters) and carotenoids. Triterpenoids are known to have antibacterial and anti-inflammatory actions, which can help treat infections and reduce inflammation in the body. Using in vivo pharmacological testing, it has been determined that the triterpenoid fatty acid esters are responsible for the anti-inflammatory effects of Calendula. In particular, HPLC analysis identified triterpene esters that showed a concentration-dependent inhibition of the NF-κB driven transcription, with faradiol-3-myristate and the corresponding aglycone being the most active compounds.

Flavonoids

Analysis of 23 varieties of C. officinalis flowers allowed researchers to select the Greenheart Orange variety due to the superior content of flavonoids (46.87 mg/g) and the highest inhibitory activity against acetylcholinesterase (IC₅₀ 63.52 µg/mL). Flavonoids, isorhamnetin, and quercetin derivatives were revealed as potential inhibitors with the application of HPLC activity-based profiling. The anti-inflammatory effect of flavonoids occurs through the suppression of prostaglandin synthesis, while carotenoids support tissue repair and regeneration. According to the European Pharmacopoeia, the minimal condition of quality was 0.4% total flavonoids expressed in quercetin equivalents (QE).

Carotenoids

Due to their orange colour, marigold flowers are characterized by a high presence of carotenoids. Carotenoids found in the stem and leaves of C. officinalis include violaxanthin, 9Z-Violaxanthin, 9Z-Neoxanthin, antheraxanthin, neoxanthin, mutatoxanthin, 9/9′Z-Lutein, β-carotene, α-cryptoxanthin, lutein, luteoxanthin, β-cryptoxanthin, and 13Z-Violaxanthin. The flowers are a rich source of lutein, containing 29.8 mg/100g. Carotenoids are predominantly known for their antioxidant activity through a radical scavenging mechanism, which makes them extremely useful in the pharmacotherapy of oxidative disorders. The same antioxidant potential and their ability to form artificial cross-linkage make them possess wound-healing action.

Polysaccharides

Polysaccharides include a rhamnoarabinogalactan and two arabinogalactans with different molecular masses. Antitumour and phagocytosis-stimulation properties have been reported for the polysaccharide fraction.

Essential Oils and Other Constituents

At least 15 compounds have been identified in the essential oil. Studies on the essential oil of C. officinalis flowers obtained sesquiterpene alcohol and mainly α-cadinol by using steam distillation. The main active components of calendula are sesquiterpene and flavonol glycosides, triterpenoid saponins, triterpene alcohols, flavonoids, carotenoids, xanthophylls, phenolic acids, sterols, mucilage, tocopherols, calendulin, and bitters.

Established Mechanisms of Action

Several studies, both in vitro and in vivo, demonstrated the biological properties of preparations from marigold flowers as antioedematous agents, in wound healing, and for their antioxidant properties. Among secondary metabolites, the flavonoids, the carotenoids, and the triterpene fatty acid esters appear to be the major contributors responsible for the anti-inflammatory activity of Calendula officinalis.

At the molecular level, to investigate whether marigold might exert an activity against gastric inflammation, a CH₂Cl₂ extract obtained from C. officinalis flowers was evaluated in vitro on the NF-κB pathway. The lipophilic extract demonstrated a significant inhibitory effect on the NF-κB driven transcription. Zeaxanthin, a non-provitamin A carotenoid belonging to the xanthophyll family, is known to have a beneficiary therapeutic effect on age-related macular degeneration through its antioxidant and blue-filtering potential.

Research has found that while triterpenes may play a minor role, tetraterpenic compounds such as carotenoids or their derivatives may be more useful in the treatment of wound healing. Further, tetraterpene extracts from C. officinalis flower are considered responsible for a protective role against hepatotoxicity and nephrotoxicity. These activities are attributed to the presence of different carotenoids such as lutein, zeaxanthin, and lycopene.

4. Scientific Evidence by Area of Use

4.1 Wound Healing (Acute and Chronic Wounds)

A systematic review evaluated the role of Calendula officinalis flower extract as monotherapy compared to control for wound healing in vivo. Searches were conducted in PubMed, EMBASE, Cochrane Central Register of Controlled Trials, CINAHL, and Scopus (up to April 2018), with 14 studies meeting the inclusion criteria, comprising 7 animal experiments and 7 clinical trials.

Animal studies provide moderate evidence for improved recovery from the inflammation phase and increased production of granulation tissue in calendula extract treatment groups. This review identified some evidence for the beneficial effects of C. officinalis extract for wound healing, consistent with its role in traditional medicine.

Regarding chronic wounds: two clinical control studies on venous ulcers demonstrated decreased ulcer surface area compared to controls. Another randomized clinical trial demonstrated no improvement for the calendula group in diabetic leg ulcer healing. Specifically, in a study evaluating effects of calendula 7.5% extract over a treatment duration of 3 weeks in patients with leg ulcers due to venous insufficiency (N=34), a significantly greater reduction in total ulcer surface area was observed in the calendula group than in the control (saline solution dressing) group (41.7% vs 14.5%; P<0.05).

There is a need for larger, well-designed randomized controlled trials to assess the effect of calendula on wound healing including complications. The plant is listed in the German Commission E, European Scientific Co-operative on Phytotherapy, the British Herbal Pharmacopoeia, and World Health Organization monographs for wound healing and anti-inflammatory properties.

Evidence strength: Moderate in animal models; mixed and preliminary in human clinical trials. Regulatory monographs recognize traditional use for minor wound healing.

4.2 Radiation-Induced Dermatitis (Radiodermatitis)

Two randomized clinical trials assessed the potential for extract to prevent acute post-radiation dermatitis, with one study showing improvements compared to trolamine, while the other found no improvement compared to aqua gel cream.

Calendula officinalis was found to be more effective than trolamine and essential fatty acids, and less effective than Ching Wan Hung® for prevention and treatment of radiodermatitis. Overall data confirm the potential of Calendula officinalis for prevention and treatment of radiodermatitis, but further testing is needed.

Containing numerous polyphenolic antioxidants, calendula has been studied in both the laboratory and clinical settings for its use in treating and preventing radiation-induced skin toxicity. Despite strong evidence in the laboratory supporting calendula's mechanism of action in preventing radiation-induced skin toxicity, clinical studies have demonstrated mixed results.

Evidence strength: Preclinical evidence is strong; clinical trial results are mixed. The topic is considered to warrant further well-controlled investigation.

4.3 Oral Mucositis and Gingivitis

A randomized controlled clinical study assessed calendula's role in radiation-induced oropharyngeal mucositis. Forty patients with head and neck cancers under radiotherapy or concurrent chemoradiotherapy protocols were randomly assigned to receive either 2% calendula extract mouthwash or placebo (20 patients in each group). Patients were treated with telecobalt radiotherapy at conventional fractionation. The oropharyngeal mucositis was evaluated using the oral mucositis assessment scale (OMAS). Calendula mouthwash significantly decreased the intensity of oropharyngeal mucositis compared to placebo at week 2 (score: 5.5 vs. 6.8, p = 0.019), week 3 (score: 8.25 vs. 10.95, p < 0.0001) and week 6 (score: 11.4 vs. 13.35, p = 0.031).

There is some evidence for using Calendula officinalis L. (Grade B recommendation, Oxford Criteria) for treating oral mucositis, though the small number of studies included should be taken into account.

Regarding gingivitis, an experimental study on human subjects demonstrated that mouthwashes containing marigold extract can be effective in reducing the oral microbiome involved in the formation of bacterial dental plaque and in the occurrence of gingivitis.

Evidence strength: Preliminary positive evidence for mucositis reduction in cancer radiotherapy; small sample sizes limit conclusions. Grade B (Oxford) recommendation noted by at least one systematic review for oral mucositis.

4.4 Skin Inflammation and Dermatitis

The HMPC concluded that, on the basis of their long-standing use, calendula flower preparations can be used for treating minor inflammation of the skin (such as sunburn) and as an aid in healing of minor wounds. Marigold apolar extracts have been largely applied for external use in the treatment of skin ulcerations, eczema, and conjunctivitis.

Plant pharmacological studies have suggested that Calendula extracts may have anti-viral, anti-genotoxic, and anti-inflammatory properties in vitro. However, the weight of evidence supporting topical skin applications rests largely on traditional use and preclinical studies, with calendula ointments available for use on minor cuts, burns, and skin irritation, though evidence of their effectiveness is weak.

Evidence strength: Recognized by EMA and Commission E on the basis of long-standing traditional use; randomized controlled trial evidence in humans remains limited and of variable quality.

4.5 Burns

Burn healing similarly showed mixed results. Two animal studies demonstrated a prophylactic effect for the administration of calendula extract prior to burn injury. A randomized clinical trial of patients suffering from partial to full thickness burns demonstrated no benefit for topical application of calendula extract compared to controls.

Evidence strength: Insufficient human clinical evidence; animal data is supportive but does not translate clearly to benefit in clinical trials to date.

4.6 Eye Health: Lutein and Zeaxanthin

C. officinalis is commercially recognized as one of the most important botanical sources of lutein. Zeaxanthin, a non-provitamin A carotenoid belonging to the xanthophyll family, is known to have a beneficiary therapeutic effect on age-related macular degeneration through its antioxidant and blue-filtering potential. Notably, Calendula officinalis Linn. contains the highest quantity of lutein in the orange variety of its flowers, and lutein protects the eyes from free radicals associated with UV rays on the eye retina. It should be noted, however, that the clinical evidence for lutein and zeaxanthin in eye health has been established through studies using these carotenoids in isolation or from combined dietary sources, rather than through clinical trials of whole calendula flower preparations for eye disease.

Evidence strength: C. officinalis is a scientifically verified source of lutein and zeaxanthin. The clinical evidence for these specific carotenoids in macular health is well-established independently; evidence for whole calendula preparations in eye disease specifically is absent from the clinical trial literature.

4.7 Gastrointestinal Applications

Calendula is used internally for the alleviation of gastrointestinal disorders. C. officinalis has been largely known for its topical anti-inflammatory properties; however, investigation of its antiphlogistic effect at the gastric level showed that a CH₂Cl₂ extract obtained from C. officinalis flowers evaluated in vitro on the NF-κB pathway demonstrated a significant inhibitory effect on NF-κB driven transcription. Clinical studies have tested calendula's therapeutic properties against ulcers, among other conditions.

Evidence strength: Preclinical (in vitro) evidence supports a mechanistic basis for anti-inflammatory effects on the gastric mucosa. Human clinical evidence for gastrointestinal indications is very limited and not yet sufficient to draw firm conclusions.

4.8 Antimicrobial Activity

In an in vitro assay, the methanol extract of C. officinalis exhibited antibacterial activity, and both the methanol and the ethanol extracts showed antifungal activities. Studies identified the minimum inhibitory concentration (MIC) for Calendula officinalis as being 62.5 mg/ml for Porphyromonas gingivalis and 250 mg/ml for Aggregatibacter actinomycetemcomitans.

Evidence strength: Evidence is limited to in vitro studies. No clinical trials have evaluated calendula as a standalone antimicrobial agent in humans.

4.9 Antitumour Activity

Polysaccharides isolated from C. officinalis include a rhamnoarabinogalactan and two arabinogalactans; antitumour and phagocytosis-stimulation properties have been reported for the polysaccharide fraction. The chemical constituents of C. officinalis confer biological effects including anti-cancer activity. However, these findings are derived from in vitro and animal models. No clinical trials in humans have established calendula preparations as effective antitumour agents.

Evidence strength: Preliminary, in vitro only. Clinical evidence in humans is absent.

5. Body Systems and Health Areas

• Integumentary System (Skin): Wound healing, hepatoprotective, and antioxidant activities. Also employed in cases of certain burns and skin conditions.
• Oral and Mucosal Health: Uses in dentistry include treatment of oral mucositis, angular cheilitis, bone loss in periodontitis, leukoplakia, and also used as a root canal irrigant, intracanal medicament, and anti-plaque and anti-gingivitis agent.
• Gastrointestinal System: Calendula has a long history as a traditional remedy for ulcers and digestive problems.
• Ocular Health: Zeaxanthin, present in calendula, is known to have a beneficiary therapeutic effect on age-related macular degeneration through its antioxidant and blue-filtering potential.
• Gynaecological: Used for gynaecological issues and menstrual irregularities in Homoeopathic, Unani, and Ayurvedic systems.
• Immune/Inflammatory: Calendula exhibits excellent anti-inflammatory activity; alkaloids, tannins, flavonoids, essential oils, sterols, saponins, carotenoids, triterpene alcohols, mucilage, polysaccharides, and resin are among the categories of secondary metabolites correlated with anti-inflammatory characteristics.

6. Dosage Forms and Dosages Reported in Studies

According to the WHO monograph on medicinal plants, the recommended methods include use of an infusion or tincture of 1–2 g/150 mL for topical application, a 40% alcohol extract for external use, and a 2–5% ointment for treatment of wounds and compresses.

In clinical studies, the following specific concentrations and regimens have been reported:

• A calendula 7.5% extract ointment was applied topically for 3 weeks in a study of patients with leg ulcers due to venous insufficiency.
• A methanol 1% extract of calendula flowers as a cream was topically applied nightly for 7 days in a study of women with vaginal candidiasis.
• A 2% calendula extract mouthwash was used over the course of radiotherapy treatment in a study of 40 patients with head and neck cancers.
• A calendula ointment was investigated following episiotomy in a parallel-group randomized trial of women with singleton pregnancies, with participants assigned to use either calendula ointment 4 hours after episiotomy and then every 8 hours for 10 days, or standard care.
• In a small clinical study (N=32) evaluating management of diabetic foot ulcers, patients received C. officinalis oil (5 mL) over 30 days, alone or in combination with low-level laser therapy.

Various topical dosage forms and preparations have been evaluated in clinical studies; however, data are lacking regarding specific strengths/concentrations used, and trials are associated with methodological limitations, making dosing recommendations difficult.

Regarding traditional oral preparations: traditionally, preparations have been made by steeping 5 to 10 mL of the herb in 240 mL (1 cup) of boiling water for 10 minutes and then gargled as a mouthwash for oral applications.

7. Safety Considerations and Interactions

General Safety Profile

No toxicity was reported in the clinical studies evaluating calendula for ulcers, radiodermatitis, burn wounds, plaque, and gingivitis. This review highlights that various monographs and medicine agencies have certified Calendula as safe. Calendula is "generally recognized as safe" (GRAS) as a food by the U.S. Food and Drug Administration when used as a seasoning or flavoring.

Allergic Reactions and Contact Sensitivity

Allergic reactions, contact sensitization, and one case of anaphylaxis have been reported. Calendula is part of the Asteraceae (daisy) family of plants. People who have allergies to other plants in this family may be more likely to have an allergic reaction to calendula. Examples of other common plants in the Asteraceae family include arnica, echinacea, chamomile, yarrow, ragweed, asters, and chrysanthemums.

Several studies have assessed the sensitisation potential of Calendula officinalis in patients with contact allergic dermatitis. In a multicentre study involving 119 subjects using the European standard series and a 10% alcoholic extract of calendula, only one positive reaction was reported, indicating a low sensitisation potential.

Pregnancy and Lactation

The European Scientific Cooperative on Phytotherapy (ESCOP) does not recommend the topical use of calendula since there is no data to determine its safety during pregnancy. Information regarding safety and efficacy in pregnancy and lactation is lacking. In a study in rats, a hydroalcoholic extract of C. officinalis did not demonstrate toxic effects on male fertility or during the early and mid-pregnancy periods in females. However, during the fetal period of pregnancy (i.e., after the 10th week), a reduction in maternal weight gain was noted in rats receiving the extract.

No safety studies are available on the use of calendula flowers during pregnancy and lactation or for use in children under 6 years old. Oral Calendula has no specific lactation-related uses and no information is available on the oral use of Calendula during breastfeeding.

Drug Interactions

No well-documented drug interactions have been established. Calendula may interact with CNS depressants and cause breathing difficulties and excessive sleepiness. In two clinical studies of patients with bacterial vaginosis or vaginal candidiasis, itching was reported more frequently with vaginally applied calendula cream than with comparator creams.

Animal Toxicology Data

Animal studies noted that higher doses of calendula consumption lowered blood pressure and blood sugar, and also led to mild ocular irritation, hepatotoxicity, and renal overload. Since further studies testing for such side effects in humans are inconclusive, experts suggest caution.

Distinction from Tagetes Species

When growing or picking calendula flowers, ensure the plants are Calendula officinalis and not Tagetes species, of which the French, African, and Mexican marigolds are common. These have different properties and must not be used for herbal teas.

References

• ScienceDirect Topics: Calendula officinalis — overview (Trease and Evans' Pharmacognosy, 16th ed.)
• Calendula officinalis — A Comprehensive Review, ScienceDirect (2024)
• Antifungal activity of the essential oil from Calendula officinalis L. (Asteraceae) growing in Brazil — PMC
• Calendula officinalis — Wikipedia
• Isorhamnetin and Quercetin Derivatives as Anti-Acetylcholinesterase Principles of Marigold (Calendula officinalis) Flowers and Preparations — PMC (2017)
• The Mediterranean Species Calendula officinalis and Foeniculum vulgare as Valuable Source of Bioactive Compounds — PMC (2024)
• Evaluation of Biologically Active Compounds from Calendula officinalis Flowers using Spectrophotometry — PMC (2012)
• A Review on Traditional Uses, Phytochemistry and Pharmacological Activities of Calendula officinalis Linn — SAGE Journals (2024)
• Calendula — Wikipedia
• Herbs in History: Calendula — American Herbal Products Association
• Isolation of Bioactive Compounds (Carotenoids, Tocopherols, and Tocotrienols) from Calendula officinalis L. — PMC (2024)
• A Bio-Guided Fractionation to Assess the Inhibitory Activity of Calendula officinalis L. on the NF-κB Driven Transcription in Human Gastric Epithelial Cells — PMC (2015)
• An Updated Review on the Multifaceted Therapeutic Potential of Calendula officinalis L — PMC (2023)
• A Review on Phytochemistry and Ethnopharmacological Aspects of Genus Calendula — PMC (2013)
• Calendula in Modern Medicine: Advancements in Wound Healing and Drug Delivery Applications — ScienceDirect (2024)
• A Systematic Review of Calendula officinalis Extract for Wound Healing — PubMed (2019)
• A Systematic Review of Calendula officinalis Extract for Wound Healing — Wound Repair and Regeneration (Wiley, 2019)
• A Review of the Use of Topical Calendula in the Prevention and Treatment of Radiotherapy-Induced Skin Reactions — PubMed (2016)
• A Review of the Use of Topical Calendula in the Prevention and Treatment of Radiotherapy-Induced Skin Reactions — PMC (2015)
• Effectiveness of Skin Protectors and Calendula officinalis for Prevention and Treatment of Radiodermatitis: An Integrative Review — PubMed (2020)
• Antioxidant Capacity of Calendula officinalis Flowers Extract and Prevention of Radiation Induced Oropharyngeal Mucositis: A Randomized Controlled Clinical Study — PMC (2013)
• How to Bridge the Gap? European Medical Plants Used for Treating Oral Mucositis: On the Search for Evidence — PMC (2020)
• Evaluation of Calendula officinalis as an Anti-Plaque and Anti-Gingivitis Agent — PMC (2013)
• An Update of Phytotherapeutic Advances of Marigold (Calendula officinalis L.) in Wound Healing — PMC (2025)
• Calendulae flos — European Medicines Agency (EMA)
• Calendulae flos (Calendula Flower) — ESCOP Herbal Monograph (2019)
• Calendula — Drugs and Lactation Database (LactMed®), NCBI Bookshelf
• Calendula Uses, Benefits & Dosage — Drugs.com Natural Products Database
• Enhancement of Lutein Content in Calendula officinalis Linn. By Solid-State Fermentation — PMC (2022)
• Lutein, Zeaxanthin, and meso-Zeaxanthin: The Basic and Clinical Science Underlying Carotenoid-based Nutritional Interventions against Ocular Disease — PMC (2015)